1. Home
  2. 3-(cyclopropylmethoxy)azetidine

Contact Angene

Tel: +852 8191 6999

Email: [email protected]

Brc1cnc(nc1)C
Pyrimidine, 5-bromo-2-methyl-
CCCP1(=O)OP(=O)(CCC)OP(=O)(O1)CCC
1,3,5,2,4,6-Trioxatriphosphorinane, 2,4,6-tripropyl-, 2,4,6-trioxide
CC1(C)OB(OC1(C)C)B1OC(C(O1)(C)C)(C)C
2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octamethyl-
O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]
Tris(dibenzylideneacetone)dipalladium
C1CCC(CC1)P(C1CCCCC1)C1CCCCC1.Cc1cc(C)c(c(c1)C)N1CCN(C1=[Ru](=Cc1ccccc1)(Cl)Cl)c1c(C)cc(cc1C)C
Ruthenium,[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)(tricyclohexylphosphine)-, (SP-5-41)-

3-(cyclopropylmethoxy)azetidine

N1CC(C1)OCC1CC1 Request for Quotation
Chemical Name: 3-(cyclopropylmethoxy)azetidine
CAS Number: 1219976-56-3
Product Number: AG0016IE(AGN-PC-09RSIA)
Synonyms:
MDL No:
Molecular Formula: C7H13NO
Molecular Weight: 127.1842

Identification/Properties

Safety Information

NMR Spectrum

Other Analytical Data

Request for Quotation

Customer Feedback

Chemical Structure


3-(Cyclopropylmethoxy)azetidine is a versatile compound widely utilized in chemical synthesis for its unique structural and reactivity properties. In organic chemistry, it serves as a valuable building block for the synthesis of complex molecules and pharmaceutical agents due to its stability and distinct three-dimensional structure. This compound is commonly employed as a key intermediate in the preparation of various heterocyclic compounds, such as azetidines and piperidines, through ring-opening and functional group transformations. Additionally, 3-(Cyclopropylmethoxy)azetidine finds application in the creation of chiral compounds, where its asymmetric center can be harnessed for the development of enantiopure molecules with enhanced biological activity. Moreover, its cyclopropylmethoxy moiety imparts unique physicochemical properties to the synthesized products, making it valuable in medicinal chemistry for the design of novel drug candidates with improved pharmacokinetic profiles and therapeutic potential.